C12N 2770/14042
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2770/14042 (Virus or viral particle as vehicle) appears on 6 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 13
- Assignees
- 8
- Inventors
- 23
- Latest grant
- 4 Apr 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 2 |
| 2021 | 3 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Covalently fused viral coat proteins for the display of target molecules4 Apr 2023US 11,618,771 B2Fraunhofer USA, Inc.
- Virus-enabled targeted vector for imaging21 Dec 2021US 11,202,841 B2The Trustees of Indiana University
- Covalently fused viral coat proteins for the display of target molecules3 Aug 2021US 11,078,240 B2Fraunhofer USA, Inc.
- Treatment of peanut allergy26 Jan 2021US 10,898,569 B2Allergy Therapeutics (UK) Limited
- In vitro reconstituted plant virus capsids for delivering RNA genes to mammalian cells5 Mar 2019US 10,221,399 B2The Regents of the University of California
- Active vaccination for the treatment of ngf-related disorders11 Sep 2025US 2025/0281584 A1Boehringer Ingelheim Vetmedica GmbH
- Immune checkpoint targeting therapeutic nanoparticles24 Apr 2025US 2025/0127842 A1The Regents of the University of California
- Covid assay controls31 Aug 2023US 2023/0272351 A1The Regents of the University of California
- Modified viral therapeutics and uses thereof9 Feb 2023US 2023/0038487 A1The Regents of the University of California
- Plant viral nucleic acid delivery particles and uses thereof6 Oct 2022US 2022/0313618 A1Case Western Reserve University
Most cited
By later US patents